Triple oral therapy with metformin, DPP ‐4 inhibitor, and SGLT2 inhibitor for adults with type 2 diabetes: Consensus recommendations of a Chinese expert panel (version 2025)
Methodological detailssystematic literature review, Delphi process, expert panel
- Systematic literature review
- Delphi process
- Expert panel
Recommendations
As issued by the authors
11 consensus recommendations (8 strong and 3 weak) on the clinical use of metformin + DPP-4i + SGLT2i, incl. fixed-dose combination formulations; safety considerations also described
Original publication
Triple oral therapy with metformin, DPP ‐4 inhibitor, and SGLT2 inhibitor for adults with type 2 diabetes: Consensus recommendations of a Chinese expert panel (version 2025). Diabetes Obes Metab. Published 14 October 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →